Call Name: Abby
Location: Canada (CA)
Born: 2021 Jul 23 (3 Years 5 Months ago)
Sir: Usher
Dam: Tofino von Euroline
Genotypes (Gene Name) | Category | Simple Value |
---|---|---|
MT Haplogroup () | B1_MT | |
MDR1 Drug Sensitivity (ABCB1) (MDR1) | clear | |
P2Y12 Receptor Platelet Disorder (P2Y12) (P2Y12) | clear | |
Factor IX Deficiency, Hemophilia B (F9 Exon 7, Terrier Variant) (F9 Exon 7 Variant 1) | clear | |
Factor IX Deficiency, Hemophilia B (F9 Exon 7, Rhodesian Ridgeback Variant) (F9 Exon 7 Variant 2) | clear | |
Factor VII Deficiency (F7 Exon 5) () | clear | |
Factor VIII Deficiency, Hemophilia A (F8 Exon 10, Boxer Variant) () | clear | |
Thrombopathia (RASGRP1 Exon 5, Basset Hound Variant) () | clear | |
Thrombopathia (RASGRP1 Exon 5, American Eskimo Dog Variant) () | clear | |
Congenital Macrothrombocytopenia (TUBB1 Exon 1, Cairn and Norfolk Terrier Variant) () | clear | |
Canine Elliptocytosis (SPTB Exon 30) () | clear | |
May-Hegglin Anomaly (MYH9) () | clear | |
Prekallikrein Deficiency (KLKB1 Exon 8) () | clear | |
Ligneous Membranitis, LM (PLG) () | clear | |
Congenital Hypothyroidism (TPO, Tenterfield Terrier Variant) () | clear | |
Complement 3 Deficiency, C3 Deficiency (C3) () | clear | |
Progressive Retinal Atrophy, rcd3 (PDE6A) () | clear | |
Progressive Retinal Atrophy, CNGA (CNGA1 Exon 9) () | clear | |
Progressive Retinal Atrophy, prcd (PRCD Exon 1) () | clear | |
Progressive Retinal Atrophy (SAG) () | clear | |
Golden Retriever Progressive Retinal Atrophy 1, GR-PRA1 (SLC4A3) () | clear | |
Golden Retriever Progressive Retinal Atrophy 2, GR-PRA2 (TTC8) () | clear | |
X-Linked Progressive Retinal Atrophy 1, XL-PRA1 (RPGR) () | clear | |
Progressive Retinal Atrophy, PRA3 (FAM161A) () | clear | |
Collie Eye Anomaly, Choroidal Hypoplasia, CEA (NHEJ1) () | clear | |
Autosomal Dominant Progressive Retinal Atrophy (RHO) () | clear | |
Primary Lens Luxation (ADAMTS17) () | clear | |
Macular Corneal Dystrophy, MCD (CHST6) () | clear | |
2,8-Dihydroxyadenine Urolithiasis, 2,8-DHA Urolithiasis (APRT) () | clear | |
Hyperuricosuria and Hyperuricemia or Urolithiasis, HUU (SLC2A9) () | clear | |
Polycystic Kidney Disease, PKD (PKD1) () | clear | |
Primary Hyperoxaluria (AGXT) () | clear | |
Protein Losing Nephropathy, PLN (NPHS1) () | clear | |
X-Linked Hereditary Nephropathy, XLHN (COL4A5 Exon 35, Samoyed Variant 2) () | clear | |
Congenital Keratoconjunctivitis Sicca and Ichthyosiform Dermatosis, Dry Eye Curly Coat Syndrome, CKCSID (FAM83H Exon 5) () | clear | |
Renal Cystadenocarcinoma and Nodular Dermatofibrosis, RCND (FLCN Exon 7) () | clear | |
Canine Fucosidosis (FUCA1) () | clear | |
Lagotto Storage Disease (ATG4D) () | clear | |
GM2 Gangliosidosis (HEXB, Poodle Variant) () | clear | |
Persistent Mullerian Duct Syndrome, PMDS (AMHR2) () | clear | |
Deafness and Vestibular Syndrome of Dobermans, DVDob, DINGS (MYO7A) () | clear | |
Shar-Pei Autoinflammatory Disease, SPAID, Shar-Pei Fever (MTBP) () | clear | |
Alaskan Husky Encephalopathy, Subacute Necrotizing Encephalomyelopathy (SLC19A3) () | clear | |
Alexander Disease (GFAP) () | clear | |
Spinocerebellar Ataxia, Late-Onset Ataxia, LoSCA (CAPN1) () | clear | |
Spinocerebellar Ataxia with Myokymia and/or Seizures (KCNJ10) () | clear | |
Benign Familial Juvenile Epilepsy, Remitting Focal Epilepsy (LGI2) () | clear | |
Degenerative Myelopathy, DM (SOD1A) () | clear | |
Neonatal Encephalopathy with Seizures, NEWS (ATF2) () | clear | |
Juvenile Laryngeal Paralysis and Polyneuropathy, Polyneuropathy with Ocular Abnormalities and Neuronal Vacuolation, POANV (RAB3GAP1, Rottweiler Variant) () | clear | |
Juvenile-Onset Polyneuropathy, Leonberger Polyneuropathy 1, LPN1 (LPN1, ARHGEF10) () | clear | |
Juvenile Myoclonic Epilepsy (DIRAS1) () | clear | |
Juvenile-Onset Polyneuropathy, Leonberger Polyneuropathy 2, LPN2 (GJA9) () | clear | |
Spongy Degeneration with Cerebellar Ataxia 1, SDCA1, SeSAME/EAST Syndrome (KCNJ10) () | clear | |
Spongy Degeneration with Cerebellar Ataxia 2, SDCA2 (ATP1B2) () | clear | |
Long QT Syndrome (KCNQ1) () | clear | |
Muscular Dystrophy (DMD, Cavalier King Charles Spaniel Variant 1) () | clear | |
Limb Girdle Muscular Dystrophy (SGCD, Boston Terrier Variant) () | clear | |
Inherited Myopathy of Great Danes (BIN1) () | clear | |
Myostatin Deficiency, Bully Whippet Syndrome (MSTN) () | clear | |
Hypocatalasia, Acatalasemia (CAT) () | clear | |
Malignant Hyperthermia (RYR1) () | clear | |
Episodic Falling Syndrome (BCAN) () | clear | |
Hereditary Vitamin D-Resistant Rickets (VDR) () | clear | |
Craniomandibular Osteopathy, CMO (SLC37A2) () | clear | |
Chondrodystrophy and Intervertebral Disc Disease, CDDY/IVDD, Type I IVDD (FGF4 retrogene - CFA12) () | clear | |
MHC Class II - DLA DRB1 () | 0 | |
MHC Class II - DLA DQA1 and DQB1 () | 0 | |
K Locus (CBD103) () | KyKy | |
Intensity Loci () | Intermediate | |
A Locus (ASIP) () | AtAt | |
B Locus (TYRP1) () | bb | |
Saddle Tan (RALY) () | NI | |
S Locus (MITF) () | Ssp | |
M Locus (PMEL) () | mm | |
H Locus (Harlequin) () | hh | |
Furnishings (RSPO2) () | II | |
Coat Length (FGF5) () | GG | |
Shedding (MC5R) () | TT | |
Hairlessness (FOXI3) () | N/N | |
Hairlessness (SGK3) () | NN | |
Oculocutaneous Albinism Type 2 (SLC45A2) () | N/N | |
Muzzle Length (BMP3) () | CC | |
Tail Length (T) () | CC | |
Hind Dewclaws (LMBR1) () | CC | |
Blue Eye Color (ALX4) () | N/N | |
Back Muscling & Bulk, Large Breed (ACSL4) () | CC | |
Body Size (IGF1) () | NN | |
Body Size (IGFR1) () | GG | |
Body Size (STC2) () | TT | |
Body Size (GHR - E191K) () | GG | |
Body Size (GHR - P177L) () | CC | |
Altitude Adaptation (EPAS1) () | GG | |
Coat Texture (KRT71) () | CC | |
Appetite (POMC) () | N/N | |
Factor VIII Deficiency, Hemophilia A (F8 Exon 11, German Shepherd Variant 1) () | clear | |
Factor VIII Deficiency, Hemophilia A (F8 Exon 1, German Shepherd Variant 2) () | clear | |
Thrombopathia (RASGRP1 Exon 8, Landseer Variant) () | clear | |
Von Willebrand Disease Type III, Type III vWD (VWF Exon 4, Terrier Variant) () | clear | |
Von Willebrand Disease Type III, Type III vWD (VWF Exon 7, Shetland Sheepdog Variant) () | clear | |
Von Willebrand Disease Type I, Type I vWD (VWF) () | clear | |
Von Willebrand Disease Type II, Type II vWD (VWF, Pointer Variant) () | clear | |
Glanzmann's Thrombasthenia Type I (ITGA2B Exon 12, Otterhound Variant) () | clear | |
Pyruvate Kinase Deficiency (PKLR Exon 5, Basenji Variant) () | clear | |
Pyruvate Kinase Deficiency (PKLR Exon 7, Labrador Retriever Variant) () | clear | |
Pyruvate Kinase Deficiency (PKLR Exon 7, Pug Variant) () | clear | |
Pyruvate Kinase Deficiency (PKLR Exon 7, Beagle Variant) () | clear | |
Pyruvate Kinase Deficiency (PKLR Exon 10, Terrier Variant) () | clear | |
Trapped Neutrophil Syndrome, TNS (VPS13B) () | clear | |
Severe Combined Immunodeficiency, SCID (PRKDC, Terrier Variant) () | clear | |
Severe Combined Immunodeficiency, SCID (RAG1, Wetterhoun Variant) () | clear | |
X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG Exon 1, Basset Hound Variant) () | clear | |
X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG, Corgi Variant) () | clear | |
Progressive Retinal Atrophy, rcd1 (PDE6B Exon 21, Irish Setter Variant) () | clear | |
Progressive Retinal Atrophy, PRA1 (CNGB1) () | clear | |
Progressive Retinal Atrophy, crd1 (PDE6B, American Staffordshire Terrier Variant) () | clear | |
Progressive Retinal Atrophy, crd4/cord1 (RPGRIP1) () | clear | |
Day blindness, Cone Degeneration, Achromatopsia (CNGB3 Exon 6, German Shorthaired Pointer Variant) () | clear | |
Achromatopsia (CNGA3 Exon 7, German Shepherd Variant) () | clear | |
Achromatopsia (CNGA3 Exon 7, Labrador Retriever Variant) () | clear | |
Canine Multifocal Retinopathy, cmr1 (BEST1 Exon 2) () | clear | |
Canine Multifocal Retinopathy, cmr2 (BEST1 Exon 5, Coton de Tulear Variant) () | clear | |
Canine Multifocal Retinopathy, cmr3 (BEST1 Exon 10 Deletion, Finnish and Swedish Lapphund, Lapponian Herder Variant) () | clear | |
Primary Open Angle Glaucoma (ADAMTS10 Exon 9, Norwegian Elkhound Variant) () | clear | |
Primary Open Angle Glaucoma (ADAMTS10 Exon 17, Beagle Variant) () | clear | |
Primary Open Angle Glaucoma (ADAMTS17 Exon 11, Basset Fauve de Bretagne Variant) () | clear | |
Primary Open Angle Glaucoma and Primary Lens Luxation (ADAMTS17 Exon 2, Chinese Shar-Pei Variant) () | clear | |
Hereditary Cataracts, Early-Onset Cataracts, Juvenile Cataracts (HSF4 Exon 9, Australian Shepherd Variant) () | clear | |
Congenital Stationary Night Blindness (RPE65, Briard Variant) () | clear | |
Cystinuria Type I-A (SLC3A1, Newfoundland Variant) () | clear | |
Cystinuria Type II-A (SLC3A1, Australian Cattle Dog Variant) () | clear | |
Cystinuria Type II-B (SLC7A9, Miniature Pinscher Variant) () | clear | |
Autosomal Recessive Hereditary Nephropathy, Familial Nephropathy, ARHN (COL4A4 Exon 3, Cocker Spaniel Variant) () | clear | |
Primary Ciliary Dyskinesia, PCD (CCDC39 Exon 3, Old English Sheepdog Variant) () | clear | |
X-linked Ectodermal Dysplasia, Anhidrotic Ectodermal Dysplasia, XHED (EDA Intron 8) () | clear | |
Glycogen Storage Disease Type II, Pompe's Disease, GSD II (GAA, Finnish and Swedish Lapphund, Lapponian Herder Variant) () | clear | |
Glycogen Storage Disease Type IA, Von Gierke Disease, GSD IA (G6PC, Maltese Variant) () | clear | |
Glycogen Storage Disease Type IIIA, GSD IIIA (AGL, Curly Coated Retriever Variant) () | clear | |
Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, Dachshund Variant) () | clear | |
Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, New Zealand Huntaway Variant) () | clear | |
Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 5, Terrier Brasileiro Variant) () | clear | |
Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 3, German Shepherd Variant) () | clear | |
Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Whippet and English Springer Spaniel Variant) () | clear | |
Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Wachtelhund Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 1, NCL 1 (PPT1 Exon 8, Dachshund Variant 1) () | clear | |
Neuronal Ceroid Lipofuscinosis 2, NCL 2 (TPP1 Exon 4, Dachshund Variant 2) () | clear | |
Neuronal Ceroid Lipofuscinosis, Cerebellar Ataxia, NCL4A (ARSG Exon 2, American Staffordshire Terrier Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 SNP, Border Collie Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 6, NCL 6 (CLN6 Exon 7, Australian Shepherd Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8 Exon 2, English Setter Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 7, NCL 7 (MFSD8, Chihuahua and Chinese Crested Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8, Australian Shepherd Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 10, NCL 10 (CTSD Exon 5, American Bulldog Variant) () | clear | |
Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 Deletion, Golden Retriever Variant) () | clear | |
GM1 Gangliosidosis (GLB1 Exon 15, Shiba Inu Variant) () | clear | |
GM1 Gangliosidosis (GLB1 Exon 15, Alaskan Husky Variant) () | clear | |
GM1 Gangliosidosis (GLB1 Exon 2, Portuguese Water Dog Variant) () | clear | |
GM2 Gangliosidosis (HEXA, Japanese Chin Variant) () | clear | |
Globoid Cell Leukodystrophy, Krabbe disease (GALC Exon 5, Terrier Variant) () | clear | |
Autosomal Recessive Amelogenesis Imperfecta, Familial Enamel Hypoplasia (ENAM Deletion, Italian Greyhound Variant) () | clear | |
Cerebellar Abiotrophy, Neonatal Cerebellar Cortical Degeneration, NCCD (SPTBN2, Beagle Variant) () | clear | |
Cerebellar Ataxia, Progressive Early-Onset Cerebellar Ataxia (SEL1L, Finnish Hound Variant) () | clear | |
Cerebellar Hypoplasia (VLDLR, Eurasier Variant) () | clear | |
Hereditary Ataxia, Cerebellar Degeneration (RAB24, Old English Sheepdog and Gordon Setter Variant) () | clear | |
Fetal-Onset Neonatal Neuroaxonal Dystrophy (MFN2, Giant Schnauzer Variant) () | clear | |
Hypomyelination and Tremors (FNIP2, Weimaraner Variant) () | clear | |
Neuroaxonal Dystrophy, NAD (TECPR2, Spanish Water Dog Variant) () | clear | |
L-2-Hydroxyglutaricaciduria, L2HGA (L2HGDH, Staffordshire Bull Terrier Variant) () | clear | |
Narcolepsy (HCRTR2 Intron 6, Labrador Retriever Variant) () | clear | |
Narcolepsy (HCRTR2 Exon 1, Dachshund Variant) () | clear | |
Progressive Neuronal Abiotrophy, Canine Multiple System Degeneration, CMSD (SERAC1 Exon 15, Kerry Blue Terrier Variant) () | clear | |
Progressive Neuronal Abiotrophy, Canine Multiple System Degeneration, CMSD (SERAC1 Exon 4, Chinese Crested Variant) () | clear | |
Hereditary Sensory Autonomic Neuropathy, Acral Mutilation Syndrome, AMS (GDNF-AS, Spaniel and Pointer Variant) () | clear | |
Dilated Cardiomyopathy, DCM2 (TTN, Doberman Pinscher Variant 2) () | at risk, heterozygote, dominant | |
Muscular Dystrophy (DMD, Golden Retriever Variant) () | clear | |
Myotonia Congenita (CLCN1 Exon 7, Miniature Schnauzer Variant) () | clear | |
Myotonia Congenita (CLCN1 Exon 23, Australian Cattle Dog Variant) () | clear | |
Myotubular Myopathy 1, X-linked Myotubular Myopathy, XL-MTM (MTM1, Labrador Retriever Variant) () | clear | |
Pyruvate Dehydrogenase Deficiency (PDP1, Spaniel Variant) () | clear | |
Imerslund-Grasbeck Syndrome, Selective Cobalamin Malabsorption (CUBN Exon 53, Border Collie Variant) () | clear | |
Imerslund-Grasbeck Syndrome, Selective Cobalamin Malabsorption (CUBN Exon 8, Beagle Variant) () | clear | |
Congenital Myasthenic Syndrome, CMS (CHAT, Old Danish Pointing Dog Variant) () | clear | |
Congenital Myasthenic Syndrome, CMS (COLQ, Labrador Retriever Variant) () | clear | |
Dystrophic Epidermolysis Bullosa (COL7A1, Golden Retriever Variant) () | clear | |
Ectodermal Dysplasia, Skin Fragility Syndrome (PKP1, Chesapeake Bay Retriever Variant) () | clear | |
Ichthyosis, Epidermolytic Hyperkeratosis (KRT10, Terrier Variant) () | clear | |
Ichthyosis, ICH1 (PNPLA1, Golden Retriever Variant) () | clear | |
Ichthyosis (SLC27A4, Great Dane Variant) () | clear | |
Ichthyosis (NIPAL4, American Bulldog Variant) () | clear | |
Hereditary Footpad Hyperkeratosis (FAM83G, Terrier and Kromfohrlander Variant) () | clear | |
Hereditary Nasal Parakeratosis, HNPK (SUV39H2) () | clear | |
Musladin-Lueke Syndrome, MLS (ADAMTSL2) () | clear | |
Cleft Lip and/or Cleft Palate (ADAMTS20, Nova Scotia Duck Tolling Retriever Variant) () | clear | |
Osteogenesis Imperfecta, Brittle Bone Disease (COL1A2, Beagle Variant) () | clear | |
Osteogenesis Imperfecta, Brittle Bone Disease (SERPINH1, Dachshund Variant) () | clear | |
Osteogenesis Imperfecta, Brittle Bone Disease (COL1A1, Golden Retriever Variant) () | clear | |
Osteochondrodysplasia, Skeletal Dwarfism (SLC13A1, Poodle Variant) () | clear | |
Skeletal Dysplasia 2, SD2 (COL11A2, Labrador Retriever Variant) () | clear | |
Chondrodystrophy (ITGA10, Norwegian Elkhound and Karelian Bear Dog Variant) () | clear | |
Dilated Cardiomyopathy, DCM1 (PDK4, Doberman Pinscher Variant 1) () | clear | |
E Locus (MC1R) () | EE | |
D Locus (MLPH) () | DD | |
Y Haplotype () | ||
Y Haplogroup () | ||
Alanine Aminotransferase Activity (GPT) (GPT) | at risk, heterozygote codominant | |
Glanzmann's Thrombasthenia Type I (ITGA2B Exon 13, Great Pyrenees Variant) () | clear | |
Platelet Factor X Receptor Deficiency, Scott Syndrome (TMEM16F) () | clear | |
Methemoglobinemia (CYB5R3) () | clear | |
Congenital Hypothyroidism (TPO, Rat, Toy, Hairless Terrier Variant) () | clear | |
Goniodysgenesis and Glaucoma, Pectinate Ligament Dysplasia, PLD (OLFM3) () | clear | |
Late-Onset Neuronal Ceroid Lipofuscinosis, NCL 12 (ATP13A2, Australian Cattle Dog Variant) () | clear | |
Autosomal Recessive Amelogenesis Imperfecta, Familial Enamel Hypoplasia (ENAM SNP, Parson Russell Terrier Variant) () | clear | |
Neuroaxonal Dystrophy, NAD (VPS11, Rottweiler Variant) () | clear | |
Inherited Selected Cobalamin Malabsorption with Proteinuria (CUBN, Komondor Variant) () | clear | |
Lundehund Syndrome (LEPREL1) () | clear | |
Congenital Myasthenic Syndrome, CMS (CHRNE, Jack Russell Terrier Variant) () | clear | |
Dystrophic Epidermolysis Bullosa (COL7A1, Central Asian Shepherd Dog Variant) () | clear | |
Bald Thigh Syndrome (IGFBP5) () | clear | |
Congenital Stationary Night Blindness (LRIT3, Beagle Variant) () | clear | |
Primary Ciliary Dyskinesia, PCD (NME5, Alaskan Malamute Variant) () | clear | |
Neonatal Interstitial Lung Disease (LAMP3) () | clear | |
Sensory Neuropathy (FAM134B, Border Collie Variant) () | clear | |
Cardiomyopathy and Juvenile Mortality (YARS2) () | clear | |
Inflammatory Myopathy (SLC25A12) () | clear | |
Congenital Myasthenic Syndrome, CMS (COLQ, Golden Retriever Variant) () | clear | |
Demyelinating Polyneuropathy (SBF2/MTRM13) () | clear | |
Hereditary Footpad Hyperkeratosis (DSG1, Rottweiler Variant) () | clear | |
Lethal Acrodermatitis, LAD (MKLN1) () | clear | |
Ehlers Danlos (ADAMTS2, Doberman Pinscher Variant) () | clear | |
Raine Syndrome, Canine Dental Hypomineralization Syndrome (FAM20C) () | clear | |
Cocoa (HPS3) () | NN | |
R Locus (USH2A) () | rr | |
MT Haplotype () | B1c_MT | |
Predicted Adult Weight () | 76.30 lbs | |
Coefficient Of Inbreeding () | 0.326074 |